{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:52:57Z","timestamp":1777020777471,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Earmarked Fund for China Agriculture Research System","award":["grant CARS-37"],"award-info":[{"award-number":["grant CARS-37"]}]},{"name":"The Innovation Project of Chinese Academy of Agricultural Sciences","award":["grant 25-LZIHPS-05"],"award-info":[{"award-number":["grant 25-LZIHPS-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Toxoplasma gondii<\/jats:italic> (<jats:italic>T.\u00a0gondii<\/jats:italic>) is one of the most prevalent parasites worldwide. At present, the majority of drugs used for the treatment of toxoplasmosis target the tachyzoite stage of <jats:italic>T.\u00a0gondii<\/jats:italic> and are largely ineffective against bradyzoites. Furthermore, these treatments are typically accompanied by adverse events. Consequently, there is an urgent need for the development of novel drugs that are both safe and effective against <jats:italic>T.\u00a0gondii<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 20 flavonoids were preliminarily screened for their anti-<jats:italic>T.\u00a0gondii<\/jats:italic> activity using microscopy. Next, the cell counting kit (CCK)-8 method was employed to assess the toxicity of glabridin (GLA) to host cells, while the RH strain of <jats:italic>T.0gondii<\/jats:italic>, which expresses \u03b2-galactosidase, was utilized to evaluate the inhibitory, anti-invasive, and antiproliferative effects of GLA on <jats:italic>T.\u00a0gondii<\/jats:italic>. In addition, the Prugniaud (PRU) strain was employed to investigate the impact of GLA on the bradyzoites of <jats:italic>T.\u00a0gondii<\/jats:italic>. Subsequently, the effect of GLA on the ultrastructure of <jats:italic>T.\u00a0gondii<\/jats:italic> was examined via transmission electron microscopy (TEM), followed by an assessment of the influence of GLA on the autophagy and mitochondria of <jats:italic>T.\u00a0gondii<\/jats:italic> through monodansylcadaverine (MDC), MitoTracker<jats:sup>\u2122<\/jats:sup> red CMXRos, and CM-HDCFDA and MitoSOX Red staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 20 flavonoids assessed, GLA exhibited the most potent anti-<jats:italic>T.\u00a0gondii<\/jats:italic> activity. Indeed, it significantly inhibited both the invasive and proliferative abilities of <jats:italic>T.\u00a0gondii<\/jats:italic>, thereby disrupting its lytic cycle. Moreover, GLA markedly reduced the number of bradyzoites and concurrently inhibited cyst growth. Meanwhile, ultrastructural analysis revealed that GLA induced mitochondrial swelling, membrane rupture, and autophagy in <jats:italic>T.\u00a0gondii<\/jats:italic>. Finally, fluorescent probe staining provided further evidence that GLA triggers mitochondrial dysfunction and autophagy in this parasite.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings collectively indicate that the flavonoid compound GLA exhibits significant activity against both <jats:italic>T.\u00a0gondii<\/jats:italic> tachyzoites and bradyzoites. The underlying mechanism of action potentially involves the induction of autophagy and mitochondrial dysfunction and the disruption of the membrane of <jats:italic>T.\u00a0gondii<\/jats:italic>, thereby offering new avenues for treating toxoplasmosis and establishing a theoretical reference for future research.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06695-1","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:59:21Z","timestamp":1739851161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of the flavonoid compound glabridin on tachyzoites and bradyzoites of Toxoplasma gondii"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanhua","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"6695_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1017\/S0031182021000433","volume":"148","author":"T Nayeri","year":"2021","unstructured":"Nayeri T, Sarvi S, Daryani A. Toxoplasma gondii in mollusks and cold-blooded animals: a systematic review. Parasitology. 2021;148:895\u2013903.","journal-title":"Parasitology"},{"key":"6695_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.pt.2019.07.001","volume":"35","author":"S Lourido","year":"2019","unstructured":"Lourido S. Toxoplasma gondii. Trends Parasitol. 2019;35:944\u20135.","journal-title":"Trends Parasitol"},{"key":"6695_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13071-021-04769-4","volume":"14","author":"JP Dubey","year":"2021","unstructured":"Dubey JP. Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned. Parasite Vector. 2021;14:263.","journal-title":"Parasite Vector"},{"key":"6695_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fcimb.2019.00103","volume":"9","author":"TS Lima","year":"2019","unstructured":"Lima TS, Lodoen MB. Mechanisms of human innate immune evasion by Toxoplasma gondii. Front Cell Infect Mi. 2019;9:103.","journal-title":"Front Cell Infect Mi"},{"key":"6695_CR5","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1172\/JCI136226","volume":"130","author":"X Zhao","year":"2020","unstructured":"Zhao X, Ewald SE. The molecular biology and immune control of chronic Toxoplasma gondii infection. J Clin Invest. 2020;130:3370\u201380.","journal-title":"J Clin Invest"},{"key":"6695_CR6","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965\u201376.","journal-title":"Lancet"},{"key":"6695_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006351","volume":"13","author":"OA Mendez","year":"2017","unstructured":"Mendez OA, Koshy AA. Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. Plos Pathog. 2017;13:e1006351.","journal-title":"Plos Pathog"},{"key":"6695_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpsychires.2022.07.013","volume":"153","author":"G Cossu","year":"2022","unstructured":"Cossu G, Preti A, Gyppaz D, Gureje O, Carta MG. Association between toxoplasmosis and bipolar disorder: a systematic review and meta-analysis. J Psychiatr Res. 2022;153:284\u201391.","journal-title":"J Psychiatr Res"},{"key":"6695_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.pt.2020.08.005","volume":"36","author":"G Milne","year":"2020","unstructured":"Milne G, Webster JP, Walker M. Toxoplasma gondii: an underestimated threat? Trends Parasitol. 2020;36:959\u201369.","journal-title":"Trends Parasitol"},{"key":"6695_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104434","volume":"147","author":"T Nayeri","year":"2020","unstructured":"Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Sharif M, Amouei A, Daryani A. Relationship between toxoplasmosis and autism: a systematic review and meta-analysis. Microb Pathog. 2020;147:104434.","journal-title":"Microb Pathog"},{"key":"6695_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","volume":"82","author":"M Antczak","year":"2016","unstructured":"Antczak M, Dzitko K, Dlugonska H. Human toxoplasmosis\u2014Searching for novel chemotherapeutics. Biomed Pharmacother. 2016;82:677\u201384.","journal-title":"Biomed Pharmacother"},{"key":"6695_CR12","doi-asserted-by":"publisher","first-page":"e00017","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: Historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31:e00017\u201357.","journal-title":"Clin Microbiol Rev"},{"key":"6695_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107686","volume":"216","author":"L Zhang","year":"2020","unstructured":"Zhang L, Song J, Kong L, Yuan T, Li W, Zhang W, Hou B, Lu Y, Du G. The strategies and techniques of drug discovery from natural products. Pharmacol Therapeut. 2020;216:107686.","journal-title":"Pharmacol Therapeut"},{"key":"6695_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47.","journal-title":"J Nutr Sci"},{"key":"6695_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13071-023-05849-3","volume":"16","author":"DA Abugri","year":"2023","unstructured":"Abugri DA, Wijerathne SVT, Sharma HN, Ayariga JA, Napier A, Robertson BK. Quercetin inhibits Toxoplasma gondii tachyzoite proliferation and acts synergically with azithromycin. Parasite Vector. 2023;16:261.","journal-title":"Parasite Vector"},{"key":"6695_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijpddr.2018.02.006","volume":"8","author":"H Si","year":"2018","unstructured":"Si H, Xu C, Zhang J, Zhang X, Li B, Zhou X, Zhang J. Licochalcone A: an effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo. Int J Parasitol-Drug. 2018;8:238\u201345.","journal-title":"Int J Parasitol-Drug"},{"key":"6695_CR17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3389\/fmicb.2019.02151","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Si H, Li B, Zhou X, Zhang J. Myrislignan exhibits activities against Toxoplasma gondii RH strain by triggering mitochondrial dysfunction. Front Microbiol. 2019;10:2151.","journal-title":"Front Microbiol"},{"key":"6695_CR18","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez SG, Besteiro S. The pathogenicity and virulence of Toxoplasma gondii. Virulence. 2021;12:3095\u2013114.","journal-title":"Virulence"},{"key":"6695_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.868727","volume":"12","author":"R Calero-Bernal","year":"2022","unstructured":"Calero-Bernal R, Fernandez-Escobar M, Katzer F, Su C, Ortega-Mora LM. Unifying virulence evaluation in Toxoplasma gondii: a timely task. Front Cell Infect Mi. 2022;12:868727.","journal-title":"Front Cell Infect Mi"},{"key":"6695_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2024.100552","volume":"25","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Zhai B, Bai Y, Lin H, Wu L, Luo W, Shi M, Chen S, Zhang J. In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii. Int J Parasitol-Drug. 2024;25:100552.","journal-title":"Int J Parasitol-Drug"},{"key":"6695_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","volume":"34","author":"K Kim","year":"2004","unstructured":"Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol. 2004;34:423\u201332.","journal-title":"Int J Parasitol"},{"key":"6695_CR22","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","volume":"9","author":"M Montazeri","year":"2018","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A, Aghayan SA, Daryani A. Drug resistance in Toxoplasma gondii. Front Microbiol. 2018;9:2587.","journal-title":"Front Microbiol"},{"key":"6695_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.fitote.2013.07.003","volume":"90","author":"C Simmler","year":"2013","unstructured":"Simmler C, Pauli GF, Chen SN. Phytochemistry and biological properties of glabridin. Fitoterapia. 2013;90:160\u201384.","journal-title":"Fitoterapia"},{"key":"6695_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.lfs.2007.10.019","volume":"82","author":"X Yu","year":"2008","unstructured":"Yu X, Xue C, Zhou Z, Li C, Du Y, Liang J, Zhou S. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci. 2008;82:68\u201378.","journal-title":"Life Sci"},{"key":"6695_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1556\/APhysiol.98.2011.2.14","volume":"98","author":"P Hasanein","year":"2011","unstructured":"Hasanein P. Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats. Acta Physiol Hung. 2011;98:221\u201330.","journal-title":"Acta Physiol Hung"},{"key":"6695_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2023.113687","volume":"175","author":"A Bombelli","year":"2024","unstructured":"Bombelli A, Araya-Cloutier C, Boeren S, Vincken JP, Abee T, den Besten H. Effects of the antimicrobial glabridin on membrane integrity and stress response activation in Listeria monocytogenes. Food Res Int. 2024;175:113687.","journal-title":"Food Res Int"},{"key":"6695_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pestbp.2021.104963","volume":"179","author":"C Yang","year":"2021","unstructured":"Yang C, Xie L, Ma Y, Cai X, Yue G, Qin G, Zhang M, Gong G, Chang X, Qiu X, Luo L, Chen H. Study on the fungicidal mechanism of glabridin against Fusarium graminearum. Pestic Biochem Phys. 2021;179:104963.","journal-title":"Pestic Biochem Phys"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06695-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06695-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06695-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:50:17Z","timestamp":1739879417000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06695-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6695"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06695-1","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data and materials generated or analyzed in this study are provided in the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}